Skip to main content
. 2014 Dec 14;2014(12):CD002054. doi: 10.1002/14651858.CD002054.pub3
Date Event Description
30 November 2014 New citation required but conclusions have not changed No new studies were identified for inclusion. Three new studies were identified but excluded (Dargaville 2011; Gadzinowski 2008; Lin 2014). Conclusions not changed.
30 June 2013 New search has been performed This review updates the existing review Surfactant for meconium aspiration syndrome in term and late preterm infants (El Shahed 2007).
30 June 2011 New search has been performed This review updates the existing review "Surfactant for meconium aspiration syndrome in term and late preterm infants" published in the Cochrane Database of Systematic Reviews El Shahed 2007.
One excluded study was added Dargaville 2011.
No changes to conclusions.
27 February 2008 Amended Converted to new review format.
16 May 2007 New citation required and conclusions have changed Substantive amendment
16 May 2007 New search has been performed This is an update of the review "Surfactant for meconium aspiration syndrome in full term infants" published in The Cochrane Library, Issue 2, 2002 (Soll 2002).
 The authorship of this review has been changed to: El Shahed AI, Dargaville P, Ohlsson A, Soll RF.
 
 Since this review was first published, two additional trials were identified.
 
 The increase in sample size has allowed for greater precision for some of the treatment effects. Surfactant treatment does not appear to have an effect on mortality, but does reduce the need for treatment with extracorporeal membrane oxygenation (ECMO). Surfactant treatment may reduce respiratory related outcomes and hospital stay in term/near‐term infants with meconium aspiration syndrome.